文献速递免疫规划

两种候选疫苗分别使用Montanide™ Pet Gel A或氢氧化铝佐剂对申克孢子丝菌的疗效与毒性比较(小鼠)

Comparative efficacy and toxicity of two vaccine candidates against Sporothrix schenckii using either Montanide™ Pet Gel A or aluminum hydroxide adjuvants in mice.
PubMed 文献 · Vaccine · 2017-07-04

本研究在小鼠中比较了以Montanide™ Pet Gel A(PGA)或氢氧化铝(AH)为佐剂、搭配申克孢子丝菌细胞壁蛋白(ssCWP)的候选疫苗的疗效与毒性。Balb/c小鼠接受两剂皮下接种后评估抗体水平、吞噬指数、细胞因子释放及毒性。结果显示PGA+CWP100细胞毒性更低、局部毒性更小,且肝脾真菌载量降低程度与AH+CWP100相似,提示PGA可能是未来孢子丝菌病疫苗的有效安全佐剂。

要点

  • PGA+CWP100诱导的IgG2a水平更高,可能促进巨噬细胞对申克孢子丝菌酵母的吞噬。
  • AH+CWP100诱导混合Th1/Th2/Th17细胞因子释放,PGA+CWP100以Th1/Th2为主。
  • PGA+CWP100体外细胞毒性更低、局部毒性更小,肝脾真菌载量降低与AH+CWP100相似。

核心结论

  • 结果提示PGA可能是未来孢子丝菌病疫苗的有效且安全的佐剂。

研究设计与样本

  • Balb/c小鼠在第1天和第14天接受两剂皮下接种,分为未佐剂或佐剂疫苗候选组。
  • 第21天评估抗ssCWP抗体水平(ELISA)、吞噬指数、脾细胞释放IFN-γ、IL-4、IL-17及腹腔巨噬细胞释放IL-12。
  • 体外评估疫苗制剂细胞毒性,并对接种部位进行组织病理学分析。

主要发现

  • 两种佐剂疫苗均升高抗ssCWP IgG、IgG1、IgG2a和IgG3水平,但PGA+CWP100组的IgG2a水平更高。
  • 使用PGA+CWP100免疫小鼠血清时,巨噬细胞对申克孢子丝菌酵母的吞噬作用增强。
  • AH+CWP100免疫诱导混合Th1/Th2/Th17细胞因子释放,PGA+CWP100刺激以Th1/Th2为主的细胞因子释放。
  • PGA+CWP100体外细胞毒性更低、局部毒性更小,在申克孢子丝菌或巴西孢子丝菌攻击小鼠中肝脾真菌载量降低程度与AH+CWP100相似。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Sporotrichosis is an important zoonosis in Brazil and the most frequent subcutaneous mycosis in Latin America, caused by different Sporothrix species. Currently, there is no effective vaccine available to prevent this disease. In this study, the efficacy and toxicity of the adjuvant Montanide™ Pet Gel A (PGA) formulated with S. schenckii cell wall proteins (ssCWP) was evaluated and compared with that of aluminum hydroxide (AH). Balb/c mice received two subcutaneous doses (1st and 14th days) of either the unadjuvanted or adjuvanted vaccine candidates. On the 21st day, anti-ssCWP antibody levels (ELISA), the phagocytic index, as well as the ex vivo release of IFN-γ, IL-4, and IL-17 by splenocytes and IL-12 by peritoneal macrophages were assessed. Cytotoxicity of the vaccine formulations was evaluated in vitro and by histopathological analysis of the inoculation site. Both adjuvanted vaccine formulations increased anti-ssCWP IgG, IgG1, IgG2a, and IgG3 levels, although IgG2a levels were higher in response to PGA+CWP100, probably contributing to the increase in S. schenckii yeast phagocytosis by macrophages in the opsonophagocytosis assay when using serum from PGA+CWP100-immunized mice. Immunization with AH+CWP100 led to a mixed Th1/Th2/Th17 ex vivo cytokine release profile, while PGA+CWP100 stimulated a preferential Th1/Th2 profile. Moreover, PGA+CWP100 was less cytotoxic in vitro, caused less local toxicity and led to a similar reduction in fungal load in the liver and spleen of S. schenckii- or S. brasiliensis-challenged mice as compared with AH+CWP100. These results suggest that PGA may be an effective and safe adjuvant for a future sporotrichosis vaccine.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Portuondo DL, Batista-Duharte A, Ferreira LS, et al. Comparative efficacy and toxicity of two vaccine candidates against Sporothrix schenckii using either Montanide™ Pet Gel A or aluminum hydroxide adjuvants in mice. Vaccine. 2017. PMID: 28687406. doi:10.1016/j.vaccine.2017.05.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。